Advertisement

Acta Endoscopica

, Volume 20, Issue 4, pp 415–425 | Cite as

La gastrite type B: une gastrite bactérienne: réalité ou fantaisie ?

  • J. C. Debongnie
Article
  • 3 Downloads

Résumé

Des données récentes ont permis de redéfinir la gastrite. Des entités nouvelles ont été décrites (gastrite lymphocytaire, gastrite par reflux) et surtout un nouveau germe, à tropisme gastrique, a été décrit :Helicobacter pylori. Ce germe répond aux postulats de Koch sans répondre entièrement encore aux postulats associés (relation chronologique, spécificité, relation dose-réponse, plausibilité).

Helicobacter pylori est done une cause, sans doute la principale, de gastrite chronique active. L’histoire naturelle de cette infection et les études thérapeutiques devraient nous aider à préciser son rôle exact dans les maladies du tractus digestif supérieur.

Mots-clés

gastrite Helicobacter pylori 

Type B gastritis is bacterial gastritis: fact or fancy ?

Summary

Recent developments have redefined gastritis with the description of newly recognised entities such as lymphocytic gastritis and reflux gastritis and especially with the discovery ofHelicobacter pylori. This microorganism fulfills Koch’s postulates but extended causality postulates (time-order, specificity, doseresponse relationship and plausibility) are not completely fulfilled.

ThusHelicobacter pylori is a cause, probably the main cause, of chronic active gastritis. The natural history of this infection and therapeutic studies should help us delineate it’s exact role in diseases of the foregut.

Key-words

gastritis Helicobacter pylori 

La gastritis tipo B: una gastritis bacteriana: realidad o ficcion ?

Resumen

Existen datos de reciente conocimiento que han permitido una redefinitión de la gastritis. Se han descrito nuevas tntidades (Gastritis linfocitaria, gastritis por reflujo) y, en especial un nuevo germen con tropismo gastrico se ha vista involucrado en la enfermedad : el Helicobacter pylori. Este germen responde a los postulados de Koch aun sin responder por completo a los postulados asociados (relatión cronológica, especificidad, relatión dosis-respuesta, plausibilidad).

El Helicobacter pylori es pues una causa, sin duda la más importante, de la gastritis crónica activa. La historia natural de ésta infectión y los estudios terapeúticos deberían ayudarnos a precisar su verdadero protagonismo en las enfermedades del tracto digestivo superior.

Palabras clave

gastritis Helicobacter pylori 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

De|Référence

  1. 1.
    ANDERSEN L.P., HOLCK S., POULSEN CO., ELSBORG L., JUSTESEN T. —Campylobacter pyloridis in peptic ulcer disease.Scand. J. Gastroenterol, 1987,22, 219–224.PubMedCrossRefGoogle Scholar
  2. 2.
    ANDERSEN L.P., ELSBORG L., JUSTESEN T. —Campylobacter pylori in peptic ulcer disease III Symptoms and paraclinical and epidemiologic finding.Scand. J. Gastroenterol., 1988,23, 347–350.PubMedCrossRefGoogle Scholar
  3. 3.
    BARBOSA A.J.A., QUEIROZ D.M.M., MENDEZ E.N., ROCHA G.A., LIMA G.F., OLIVEIRA C.A. — Immu-nocytochemical identification ofCampylobacter pylori in gastritis and correlation with culture.Arch. Pathol. Lab. Med., 1988,112, 523–525.PubMedGoogle Scholar
  4. 4.
    BASKERVILLE A., NEWELL D.G. — Naturally occu-ring chronic gastritis and C.pylori infection in the Rhesus monkey: a potential model for gastritis in man.Gut, 1988,29, 465–472.PubMedCrossRefGoogle Scholar
  5. 5.
    BERSTAD A., ALEXANDER B., WEBERG R., SERCK-HANSSEN A., HOLLAND S., HIRSCHOWITS. — Antacids reduceCampylobacter pylori colonization without healing the gastritis in patients with non ulcer dyspepsia and erosive prepyloric changes.Gastroenterology, 1988,95, 619–624.PubMedGoogle Scholar
  6. 6.
    BIZZOZERO G. — Über die schlauchformigen drusen des magendarmkanals und die beziehungen ihres epithets zu dem oberflachenepithel der schleimhaut.Arch. F. Mikr. Anat., 1893,42, 82–152.CrossRefGoogle Scholar
  7. 7.
    BLOMBERG B., JARNEROT G., KJELLANDER J., DANIELSSON D., KRAAZ W. — Prevalence ofCampylobacter pylori in an unselected Swedish population of patients referred for gastroscopy.Scand. J. Gastroenterol., 1988,23, 358–362.PubMedCrossRefGoogle Scholar
  8. 8.
    BODE G., MALFERTHEIMER P., DITSCHUNEIT H. — Pathogenic implications of ultrastructural finding inCampylobacter pylori related gastroduodenal disease.Scand. J. Gastroenterol., 1988,23S142, 25–39.CrossRefGoogle Scholar
  9. 9.
    BUCK G.E., GOURLEY W.K., LEE W.K., SUBRAMA-MYAN K., LATIMER J.M., DI MUZZO A.R. — Relation ofCampylobacter pyloridis to gastritis and peptic ulcer.J. Infect. Dis., 1986,153, 664–669.PubMedGoogle Scholar
  10. 10.
    CARRICK J., LEE A., HAZELL S., RALSTON M., DASKALOPOULOS G. —Campylobacter pylori, duodenal ulcer and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis.Gut, 1989,30, 790–797.PubMedCrossRefGoogle Scholar
  11. 11.
    COELHO L.G.V., DAS S.S., PAYNE A., KARIM Q.H., BARON J.H., WALKER M.M. —Campylobacter pylori association with antral and fundic mucosal histology and diagnosis by serology in patients with upper gastrointestinal symptoms.Am. J. Gastroenterol., 1989,84, 367–371.Google Scholar
  12. 12.
    DEBONGNIE J.C., LEGROS G., BEYAERT C. — La gastrite àCampylobacter pylori. Comparaison de plusieurs méthodes diagnostiques.Acta Gastroent. Belg., 1987,50, 666–673.PubMedGoogle Scholar
  13. 13.
    Dupebongnie J.C., Bupeyaert C, Lupegros G. — A large follow-up study of patients with and without itCampylobacter pylori. A retrospective analysis. In gastroduodenal pathology and itCampylobacter, pylori. Ed. Megraud F., La-mouliatte H., Excerpta Medical, 1989. Amsterdam, 459-462.Google Scholar
  14. 14.
    DELTENRE M., NYST J.F., GLUPCZYNSKI Y., BURETTE A. — Donnees cliniques, endoscopiques et histologiques chez 1 100 patients dont 574 colonisés parCampylobacter pylori. Gastroenterol. Clin. Biol., 1989,13, 89B-95.Google Scholar
  15. 15.
    DOOLEY C.P., McKENNA D., HUMPHREYS H., BOURKE S., DEANE C.T., SWEENEY E., O’MORAIN C. — Histological gastritis in duodenal ulcer: Relationship toCampylobacter pylori and effect of ulcer therapy.Am. J. Gastroenterol., 1988,83, 278–282.PubMedGoogle Scholar
  16. 16.
    DOOLEY C.P., COHEN H., FITZGIBBONS PL., BAUER M., APPLEMAN M., PEREZ-PEREZ G., BLA-SER M.J. — Prevalence ofHelicobacter pylori infection and histologic gastritis in asymptomatic persons.New Engl. J. Med., 1989,321, 1362–1366.CrossRefGoogle Scholar
  17. 17.
    DROY-LEFAIX M.T. — Mecanismes de defense de l’esto-mac etCampylobacter pylori. Gastroenterol. Clin. Biol., 1989,13, 13B-17B.PubMedGoogle Scholar
  18. 18.
    FOX J.G., CORREA P., TAYLOR M.C, ZAVALA D., FONTHAM E., JANNEY F., RODRIGUEZ E., HUNTER F., DIAVOLITSIS S. —Campylobacter pylori-asso ciated gastritis and immune response in a population at increased risk of gastric carcinoma.Amer. J. Gastroent., 1989,84, 775–781.PubMedGoogle Scholar
  19. 19.
    GAD A., HRADSKY M., FURUGARD K., MALMO-DIN B., NYBERG O. —Campylobacter pylori and non-ulcer dyspepsia.Scand. J. Gastroenterol., 1989,24 (Suppl. 167), 44–48.CrossRefGoogle Scholar
  20. 20.
    GOODWIN C.S., ARMSTRONG J.A., CHIVERS T., PETERS M., COLLINS D., SLY L., MCCONNEL W., HARPER W.E.S. — Transfer ofCampylobacter pylori andCampylobacter mustelac toHelicobacter gen now asHelicobacter pylori comb. nov. and Helicobacter mustelac comb, nov. respectively.Int. J. Syst. Bacterial, 1989,39, 397–405.CrossRefGoogle Scholar
  21. 21.
    GRAHAM ETY., ALPERT L.C., SMITH L., YOSHI-MURA H.H. — IatrogenicCampylobacter pylori infection is a cause of epidemic achlorhydria.Amer. J. Gastroent., 1988?,83, 974–980.PubMedGoogle Scholar
  22. 22.
    HAOT J., DELOS M., WALLEZ L., HARDY N., LEN-ZEN B., JOURET-MOURIN A. — Intraepithelial lymphocytes in inflammatory gastric pathology.Acta en-doscop., 1986,16, 61–67.Google Scholar
  23. 23.
    HAOT J., JOUREZ A., WILLETTE M., GOSSUIN A., MAINGUET P. — Lymphocytic gastritis — prospective study of its relationship with varioliform gastritis.Gut, 1990,31, 282–285.PubMedCrossRefGoogle Scholar
  24. 24.
    HAZELL S.L., BORODY T.J., GAL A., LEE A. —Campylobacter pyloridis Gastritis I: Detection of urease as a marker of bacterial colonization and gastritis.Am. J. Gastroent., 1987,82, 292–296.PubMedGoogle Scholar
  25. 25.
    HAZELL S.L., HENNESSY W.B., BORODY T.J., CARRICK J., RALSTON M., BRADY L., LEE A. —Campylobacter pyloridis Gastritis II: Distribution of bacteria and associated inflammation in the gastroduodenal environment.Am. J. Gastroent., 1987,82, 297–301.PubMedGoogle Scholar
  26. 26.
    HESSEY S.J., SPENCER J., WYATT J.I., SOBALA G., RATHBONE B.J., AXON ATR., DIXON M.F. — Bacterial adhesion and disease activity inHelicobacter associated chronic gastritis.Gut, 1990,31, 134–138.PubMedCrossRefGoogle Scholar
  27. 27.
    HUMPHREYS H., BOURKE S., DOOLEY C, MCKENNA D., POWER D., KEANE C.T., SWEENEY E.C., O’SMORAIN C. — Effect of treatment onCampylobacter pylori in peptic disease: a randomised prospective trial.Gut, 1988,29, 279–283.PubMedCrossRefGoogle Scholar
  28. 28.
    JIANG S.J., LIU W.Z., ZHANG D.Z., SHI Y., XIAO S.D., ZHANG Z.H., LU D.Y. —Campylobacter-like organisms in chronic gastritis, peptic ulcer and gastric carcinoma.Scand. J. Gastroenterol, 1987,22, 553–558.PubMedCrossRefGoogle Scholar
  29. 29.
    JOHNSTON B.J., REED P.I., ALI M.H. —Campylobac-ter-tike organisms in duodenal and antral endoscopic biopsies: relationship to inflammation.Gut, 1986,027, 1132–1137.CrossRefGoogle Scholar
  30. 30.
    JOHNSTON B.J., REED P.I., ALI M.H. — Prevalence ofCampylobacter pylori in duodenal and gastric mucosa -Relationship to inflammation.Scand. J. Gastroenterol, 1988,23S142, 69–75.CrossRefGoogle Scholar
  31. 31.
    JONES D.M., CURRY A., FOX A.J. — An ultrastructural study of the gastriccampylobacter-Like organisms « Campylobacter pyloridis ».J. Gen. Micro Biol, 1985,131, 2535–2541.Google Scholar
  32. 32.
    JONSSON K.A., GOTTHARD R., BODEMAR G., BRODIN U. — The clinical relevance of endoscopic and histologic inflammation of gastroduodenal mucosa in dyspepsia of unknown origin.Scand. J. Gastroenterol, 1989,24, 385–395.PubMedCrossRefGoogle Scholar
  33. 33.
    JONSSON K.A., STROM M., BODEMAR G., MOR-RBY K. — Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease.Scand. J. Gastroenterol., 1989,23, 433–441.CrossRefGoogle Scholar
  34. 34.
    KANG J.Y., TAY H.H., WEE A., GUAN R., MATH M.V., YAP I. — Effect of colloïdal bismuth subcitrate on symptoms and gastric histology in non ulcer dyspepsia. A double blind placebo controlled study.Gut, 1990,31, 476–480.PubMedCrossRefGoogle Scholar
  35. 35.
    KRAKOWA S., MORGAN D.R., KRAFT W.G., LEUNK R.D. — Establishment of gastricCampylobacter pylori infection in the neonatal gnotabiotic piglet.Infect. Immun., 1987,55, 2789–2796.Google Scholar
  36. 36.
    LAMBERT JR., DONN K., BORROMEO M., KOR-MAY M.G., HANSKY J., SMITH A.C. —Campylobacter pylori — a role in non-ulcer dyspepsia?Scand. J. Gastroenterol., 1989,24S160, 14–18.Google Scholar
  37. 37.
    LAMOULIATTE H., MEGRAUD F., DE MASGAREL A., ROUX D., QUINTON A. —Campylobacter pyloridis and epigastric pain: endoscopic, histological and bacteriological correlations.Gastroenterol. Clin. Biol, 1987,II, 212–216.Google Scholar
  38. 38.
    LANZA F.L., SKOGLUND M.L., RACK M.F., YARD-LEY J.Y. — The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: A placebo-controlled randomized study. Amer. J. Gastroent., 1989,84, 1060–1064.PubMedGoogle Scholar
  39. 39.
    LE BODIC M.F., BARRE P., FREGAND C., LE BODIC L., GALMICHE J.P. —Campylobacter pyloridis et muqueuse gastrique: étude histologique, bactériologique et résultats préliminaires d’une enquête épidémiologique dans la région nantaise.Gastroenterol. Clin. Biol, 1987,11, 376–381.Google Scholar
  40. 40.
    LOFFELD R.J.L.F., POTTERS H.V.J.P., STOBBE-RINGH E., FLENDRIG J.A., VAN SPREEUWEL J.P., ARENDS J.W. —Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.Gut, 1989,30, 1206–1212.PubMedCrossRefGoogle Scholar
  41. 41.
    MANGANARO M., CASALE V., ACETI A., ATTANA-SIO R., CITARDA F., CONTI EMS., CUNEGO A., FERRO S., GRASSI A., PENNI A., SCIARRETTA F., SCINICARIELLO F. —Campylobacter pylori et gastrite: etude biologique, immunologique, histologique et en-doscopique.Acta endosc, 1988,18, 91–96.CrossRefGoogle Scholar
  42. 42.
    MARCHEGIANNO A., IANOMMI C., AGNELLO M., PAOLUZZI P., PALLONE F. —Campylobacter-like organisms in the human gastric mucosa. Relationship to type and extent of gastritis in different clinical groups.Gastroenterol. Clin. Biol., 1987,II, 376–381.Google Scholar
  43. 43.
    MARSHALL B. — Unindentifed curved bacilli on gastric epithelium in active chronic gastritis.Lancet, 1983,1, 1273–1275.Google Scholar
  44. 44.
    MARSHALL B.J., ROYCE H., ANNEAR D.J., GOODWIN C.S., PEARMAN J.W., WARREN J.R., ARMSTRONG J.A. — Original isolation ofCampylobacter pyloridis from human gastric mucosa.Microbios. Letters, 1984,25, 83–88.Google Scholar
  45. 45.
    MARSHALL B.J., ARMSTRONG J.A., MCGECHIE D.B., GLANCY R.J. — Attempt to fulfill Koch’s postulates forCampylobacter pyloridis.Med. J. Aust., 1985,142, 436–439.PubMedGoogle Scholar
  46. 46.
    MARSHALL B.J., WARREN J.R., FRANCIS G.J., LANGTON S.R., GOODWIN C.S., BLINCOW E. — Rapid urease test in the management ofCampylobacter pyloridis-associated gastritis.Am. J. Gastroent., 1987,82, 200–210.PubMedGoogle Scholar
  47. 47.
    MARSHALL B.J. — Etudein vivo deCampylobacter pylori — Modeles experimentaux.Gastroenterol. Clin. Biol., 1989?,13, 50B-52.PubMedGoogle Scholar
  48. 48.
    MARSHALL B.J., WARREN R.J., BLINCOW E.D., PHILLIPS M., GOODWIN C.S., MURRAY R., BLACK-BOURN S.J., WATERS T.H.J., SANDERSON C.R. — Prospective double-blind trial of duodenal ulcer relapse after eradication ofCampylobacter pylori.Lancet, 1988,2, 1437–1442.PubMedCrossRefGoogle Scholar
  49. 49.
    MCNULTY C.A.M., DENT J.C., UFF J.S., GEAR M.W.L., WILKINSON S.P. — Detection onCampylobacter pylori by the biopsy urease test: an assessment in 1 445 patients.Gut, 1989,30, 1058–1062.PubMedCrossRefGoogle Scholar
  50. 50.
    MILLER N.M., NARAN A., SIMJEE A.E., SPITAELS J.M., PETTENGELL K.E., VANDEN ENDE J., MA-NION G. — Incidence ofCampylobacter pylori in patients with upper gastro-intestinal symptoms.South Afr. Med. J., 1988,74, 563–566.Google Scholar
  51. 51.
    MITCHELL H.M., LEE A., BERKOWICZ J., BORODY T. — The use of serology to diagnose activeCampylobacter pylori infection.Med. J. Austr., 1988,149, 604–609.Google Scholar
  52. 52.
    MORRIS A., MICHOLSON G. — Ingestion ofCampylobacter pyloridis causes gastritis and raised fasting gastric pH.Am. J. Gastroent., 1987,82, 192–199.PubMedGoogle Scholar
  53. 53.
    MORRIS A., BROWN P., ALI R., LANE M., PALMER R. — Treatment ofCampylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De Nol).NZ Med. J., 1988,101, 651–654.Google Scholar
  54. 54.
    MORVAN J., TEYSSOU R., BOTTON A., VIALETTE G., MEGRAUD F. —Campylobacter pylori et gastrites: Resultats a propos de 95 biopsies gastriques.Med. Mai. Inf., 1987,10, 543–548.CrossRefGoogle Scholar
  55. 55.
    MUSGROVE C, BOLTON J., KRYPCZYK A.M., TEM-PERLEY J.M., CAIRNS S.A., OWEN W.G., HUTCHINSON D.M.Campylobacter pylori: clinical, histological and serological studies.J. Clin. Pathol., 1988,41, 1316–1321.PubMedCrossRefGoogle Scholar
  56. 56.
    NEWELL D.G., JOHNSTON B.J., ALI M.H., REED P.I. — An enzyme-linked immunosorbent assay for the serodiagnosis ofCampylobacter pylori associated gastritis.Scand. J. Gastroenterol., 1988,23S142, 53–57.CrossRefGoogle Scholar
  57. 57.
    O’CONNOR H.J., WYATT J.J., DIXON M.F., AXON A.T.R. —Campylobacter-like organisms and reflux gastritis.J. Clin. Pathol., 1986,39, 531–534.PubMedCrossRefGoogle Scholar
  58. 58.
    PAULL G., YARDLEY J.H. — Gastric and esophagealCampylobacter pylori in patients with Barret’s esophagus.Gastroenterology, 1988,95, 216–218.PubMedGoogle Scholar
  59. 59.
    PETTROSS C.W., APPLEMAN M.D., COHEN H., VA-LENZUELA J.E., CHANDRASOMA P., LAINE L.A. — Prevalence ofCampylobacter pylori and association with antral mucosal histology in subjects with and without upper gastrointestinal symptoms.Dig. Dis., 1988,33, 649–653.CrossRefGoogle Scholar
  60. 60.
    PRICE A.B., LEVI J., DOLBY J.M., DUNCOMBE PL., SMITH A., CLARK J., STEPHENSON M.L. —Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology and scanning electon microscopy.Gut, 1985,26, 1183–1188.PubMedCrossRefGoogle Scholar
  61. 61.
    QUEIROZ D.M.M., BARBOSA A.J.A., MENDES E.N., ROCHA G.A., CISALPINO E.O., LIMA G.F., OLIVEI-RA C.A. — Distribution ofCampylobacter pylori and gastritis in the stomach of patients with and without duodenal ulcer.Amer. J. Gastroent., 1988,83, 1368–1370.PubMedGoogle Scholar
  62. 62.
    RASKOV H., LANNG G., GAARSLEV K., FISHER HANSEN B., HAUCH O. — Screening forCampylobacter pyloridis in patients with upper dyspepsia and the relation to inflammation of the human gastric antrum.Scand. J. Gastroenterol., 1987,22, 568–572.PubMedCrossRefGoogle Scholar
  63. 63.
    RATHBONE B.J., WYATT J.I., WORSLEY et at. — Systemic and local antibody responses to gastricCampylobacter pyloridis in non-ulcer dyspepsia.Gut, 1986,27, 642–647.PubMedCrossRefGoogle Scholar
  64. 64.
    RAUWS E.A.J., LANGENBERG W., HOUTHOFF H.J., ZANEN J.C., TYTGAT G.M.J. —Campylobacter pylori-dis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.Gastroenterology, 1988,94, 33–40.PubMedGoogle Scholar
  65. 65.
    Rupauws E.A.J., Tupytgat G.N.J., Lupangenberg W., Rupoyen E.V. — Experience with 14 c-urea breath test in detecting itCampylobacter pylori. In itCampylobacter pylori. Ed. Menge Springer Verlag, 1988, pp. 151-156.Google Scholar
  66. 66.
    RIARD PH., HOSTEIN J., CROIZE J., BOURGUI-GNON G., LEMARC HADOUR F., FAURE H., FOURNET J. — LeCampylobacter pylori: valeur dia-gnostique de l’uréase test pratiqué en salle d’endoscopie.Gastroenterol. Clin. Biol., 1989,13, 8–13.PubMedGoogle Scholar
  67. 67.
    ROKKAST., PURSEYC, VZOECHINA E., DOR-RINGTON L., SIMMONS N.A., FILIPE M.J., SLADEN G.E. —Campylobacter pylori and non-ulcer dyspepsia.Am. J. Gastroent., 1987,82, 1149–1152.Google Scholar
  68. 68.
    SIURALA M., SIPPONEN P., KEKKI M. —Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa.Gut, 1988,29, 909–915.PubMedCrossRefGoogle Scholar
  69. 69.
    SPILKER B. — Concept of cause and effect. In: Spliker B. Guide to clinical interpretation of date. New York Raven Press, 1986, 19–26.Google Scholar
  70. 70.
    VAIRA D., HOLTON J., OSBORN J., DOWSETT J., McNEIL I., HATFIELD A. — Use of endoscopy in patients with dyspepsia.Br. Med. J., 1989,299, 237.CrossRefGoogle Scholar
  71. 71.
    VON WULFFEN H., HEESEMANN J., BUTZOW G.H., LOMING T., LAUFS R. — Detection ofCampylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test and immunoblot.J. Clin. Microbiol., 1986,24, 716–720.PubMedGoogle Scholar
  72. 72.
    WHITEHEAD R., TRUELOVE S.C., GEAR M.W.L. — The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens.J. Clin. Pathol., 1972,25, 1–11.PubMedCrossRefGoogle Scholar
  73. 73.
    WORMSLEY K.G. —Campylobacter pylori and ulcer disease — A causal connection?Scand. J. Gastroentero0l., 1989,24 (Suppl. 160), 53–58.CrossRefGoogle Scholar
  74. 74.
    WYATT J.I., DIXON M.F. — Chronic gastritis — a pathogenetic approach.J. Pathology., 1988,154, 113–124.CrossRefGoogle Scholar
  75. 75.
    WYATT J.I., RATHBONE B.J. — Immune response of the gastric mucosa to Campylobacter pylori.Scand. J. Gastroenterol., 1988,23 (Suppl. 142), 44–49.CrossRefGoogle Scholar
  76. 76.
    WYATT J.I., RATHBONE B.J., DIXON M.F., HEAT-LEY R.V. —Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis.J. Clin. Pathol., 1987,80, 841–848.CrossRefGoogle Scholar
  77. 77.
    YARDLEY J.H. — Pathology of chronic duodenitis and gastritis. In gastrointestinal pathology. Ed. Goldmann H., Appelman D. Williams & Wilkins, Baltimore, 1990.Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • J. C. Debongnie
    • 1
  1. 1.Department of MedicineClinique Saint-PierreOttigniesBelgium

Personalised recommendations